[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][Branch1][C][C][O][C][=Branch1][C][=O][C][C][C][/C][=C][\\C][C@H1][C@H1][Branch2][Ring2][Branch1][C][C@H1][Branch2][Ring1][#C][C@@H1][Ring1][Branch1][/C][=C][/C@H1][Branch2][Ring1][Branch1][C][O][C][=C][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][Branch1][C][F][Branch1][C][F][F][O][O][O]"}, {"from": "gpt", "value": "The molecule is the isopropyl ester of prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of travoprost are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. It is a pro-drug; the isopropyl ester group is hydrolysed by esterases in the cornea to the biologically active free acid, fluprostenol. It has a role as an antiglaucoma drug, an antihypertensive agent, a prodrug, an ophthalmology drug and a prostaglandin receptor agonist. It is a prostaglandins Falpha, a member of (trifluoromethyl)benzenes and an isopropyl ester. It is functionally related to a fluprostenol."}]